A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : SARS-CoV-2

Search Conditions:
Search Keyword : SARS-CoV-2
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: SARS-CoV-2
Appearance Frequency: 26177 time(s)
Long forms: 92

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
severe acute respiratory syndrome coronavirus 2
(25538 times)
Medicine
(2398 times)
COVID-19 (12108 times)
ACE2 (1335 times)
RT-PCR (954 times)
2020 Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.
syndrome coronavirus 2
(332 times)
Medicine
(27 times)
COVID-19 (145 times)
ACE2 (24 times)
RT-PCR (12 times)
2020 Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
SARS coronavirus 2
(166 times)
Medicine
(18 times)
COVID-19 (58 times)
SARS (27 times)
ACE2 (22 times)
2020 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Since December 2019, a novel coronavirus
(11 times)
Medicine
(2 times)
ARDS (1 time)
AUC (1 time)
BMI (1 time)
2020 The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
Sequence of a 2019 Novel Coronavirus
(8 times)
Microbiological Phenomena
(5 times)
COVID-19 (3 times)
HLH (1 time)
2020 Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.
syndrome coronavirus 2 infection
(8 times)
Nursing
(1 time)
ICU (2 times)
COVID-19 (1 time)
ED (1 time)
2020 SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with a favourable outcome.
severe acute syndrome coronavirus 2
(7 times)
Immune System Diseases
(2 times)
ACE-2 (2 times)
ACE2 (1 time)
ANMS (1 time)
2020 Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.
syndrome-corona virus 2
(5 times)
Public Health
(1 time)
COVID-19 (1 time)
LMWH (1 time)
N protein (1 time)
2020 COVID-19, coagulopathy and venous thromboembolism: more questions than answers.
SARS-associated coronavirus-2
(3 times)
Pharmacology
(1 time)
COVID-19 (2 times)
ARDS (1 time)
DAD (1 time)
2021 The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19.
10  severe acute coronavirus 2
(3 times)
Pediatrics
(1 time)
COVID-19 (2 times)
DEGs (1 time)
GEO (1 time)
2020 Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain.
11  severe acute respiratory virus 2
(3 times)
Neoplasms
(1 time)
ACE2 (1 time)
AKI (1 time)
APOL1 (1 time)
2021 Severe Neurologic Complications of SARS-CoV-2.
12  severe coronavirus 2
(3 times)
Medicine
(1 time)
OMS (1 time)
peptide plasma (1 time)
2022 Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19.
13  anti-SARS-Coronavirus-2
(2 times)
Communicable Diseases
(1 time)
MIS-C (1 time)
nAb (1 time)
2021 COVID-19-Related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn.
14  secondary to coronavirus 2
(2 times)
Occupational Health
(1 time)
COVID-19 (1 time)
FDA (1 time)
PEEP (1 time)
2020 Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
15  severe acute respiratory infections caused by 2019 novel coronavirus
(2 times)
Allergy and Immunology
(1 time)
--- 2020 Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2).
16  stages of the novel coronavirus 2019
(2 times)
Allergy and Immunology
(2 times)
SEAIC (2 times)
STD (2 times)
HCP (1 time)
2021 High frequency of smell and taste dysfunctions in allergy health care professionals suffering from COVID-19.
17  Subsequently, coronavirus 2
(2 times)
Medicine
(2 times)
IL (2 times)
COVID-19 (1 time)
2020 COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
18  syndrome disease caused by coronavirus 2
(2 times)
Pharmacology
(1 time)
--- 2021 Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish.
19  syndrome related to coronavirus-2
(2 times)
Allergy and Immunology
(1 time)
COVID-19 (2 times)
2020 Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
20  syndrome type 2 coronavirus
(2 times)
Skin Diseases
(1 time)
NAAT (1 time)
2021 Epidemiological study in a small rural area of Veneto (Italian region) during Sars-Cov-2 Pandemia.
21  syndrome-associated coronavirus type 2
(2 times)
General Surgery
(1 time)
COVID-19 (1 time)
sgRNA (1 time)
vRNA (1 time)
2021 Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease.
22  Syndrome-related Coronavirus type 2
(2 times)
Cognitive Science
(1 time)
COVID-19 (1 time)
COVID-2019 (1 time)
PA (1 time)
2021 COVID-19 Pandemic and Physical Exercise: Lessons Learnt for Confined Communities.
23  coronavirus-Severe Acute Respiratory Syndrome-Coronavirus 2
(1 time)
COVID-19 (1 time)
2021 A Perspective on COVID-19 Management.
24  ophthalmology-specific risk of novel coronavirus 2019
(1 time)
Ophthalmology
(1 time)
PCR (1 time)
2022 Characterizing the microbiota of instrumentation in ophthalmology clinics during and beyond the COVID-19 pandemic.
25  SARS coronavirus type 2
(1 time)
Virology
(1 time)
--- 2021 Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom.
26  SARS memory on the public awareness of 2019 novel coronavirus
(1 time)
Natural Science Disciplines
(1 time)
--- 2020 The impact of social ties and SARS memory on the public awareness of 2019 novel coronavirus (SARS-CoV-2) outbreak.
27  SARS-2 Coronavirus
(1 time)
Medicine
(1 time)
WHO (1 time)
2022 COVID-19 Pandemic-to-Endemic Transition in Indonesia: What Does the Future Hold?
28  SARS-CoV and it was named coronavirus 2
(1 time)
COVID-19 (1 time)
2020 Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease.
29  SARS-like coronavirus 2
(1 time)
Molecular Biology
(1 time)
ACE2 (1 time)
COVID-19 (1 time)
RBM (1 time)
2021 Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.
30  SARS-related coronavirus-2
(1 time)
Aging
(1 time)
FDA (1 time)
2021 Global Sex Disparity of COVID-19: A Descriptive Review of Sex Hormones and Consideration for the Potential Therapeutic Use of Hormone Replacement Therapy in Older Adults.
31  Scholar, from February to October 5, 2020, focusing on COVID-19
(1 time)
Dentistry
(1 time)
ACE2 (1 time)
2021 Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection.
32  Semester of 2020, an outbreak of a novel coronavirus
(1 time)
Ecological and Environmental Phenomena
(1 time)
--- 2021 Lessons learned through listening to biology students during a transition to online learning in the wake of the COVID-19 pandemic.
33  Sensitivity evaluation of 2019 novel coronavirus
(1 time)
Medicine
(1 time)
--- 2020 Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative.
34  series of two patients with laboratory-confirmed coronavirus 2
(1 time)
Clinical Medicine
(1 time)
--- 2021 Theophylline in Treatment of COVID-19 Induced Sinus Bradycardia.
35  serious respiratory condition created by the coronavirus 2
(1 time)
Clinical Medicine
(1 time)
--- 2020 Credible Protein Targets and Curative Strategies for COVID-19: a Review.
36  serological test in the diagnosis of 2019 novel coronavirus
(1 time)
Communicable Diseases
(1 time)
SARS-CoV (1 time)
2020 Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
37  Serve-Acute-Respiratory-Coronavirus2
(1 time)
Natural Science Disciplines
(1 time)
PM (1 time)
RH (1 time)
2022 Assessing temporal correlation in environmental risk factors to design efficient area-specific COVID-19 regulations: Delhi based case study.
38  Services and the Field Hospital Experience During Coronovirus Disease 2019
(1 time)
Military Medicine
(1 time)
JNYMS (1 time)
NYC (1 time)
2021 Uniformed Services and the Field Hospital Experience During Coronovirus Disease 2019 (SARS-CoV-2) Pandemic: Open to Closure in 30 Days With 1,100 Patients: The Javits New York Medical Station.
39  severe acute coronaviral syndrome 2
(1 time)
Chemistry, Pharmaceutical
(1 time)
COVID-19 (1 time)
RdRp (1 time)
2022 One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein.
40  severe acute respiratory CoV-2
(1 time)
Microbiology
(1 time)
CoV (1 time)
2021 Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
41  severe acute respiratory illness caused by the coronavirus 2
(1 time)
Aging
(1 time)
ASCs (1 time)
COVID-19 (1 time)
MSCs (1 time)
2020 Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.
42  Severe acute respiratory infection Coronavirus 2
(1 time)
Advanced Practice Nursing
(1 time)
--- 2021 Correct Execution of the Nasopharyngeal Swab: A Fundamental Method to Improve Diagnosis of SARS-CoV-2 Infection.
43  severe cases of coronavirus 2
(1 time)
Pharmacology
(1 time)
--- 2021 Remdesivir; molecular and functional measures of mitochondrial safety.
44  severe disease and cardiac injury incorona virus 2
(1 time)
Diabetes Complications
(1 time)
ACE2 (1 time)
ACEi (1 time)
ARBs (1 time)
2021 Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
45  severe infection with the new coronavirus2
(1 time)
Otolaryngology
(1 time)
PAPR (1 time)
PEEP (1 time)
PPE (1 time)
2021 Surgical tracheostomy in acohort of COVID-19patients.
46  Severe Acute Respiratory Syndrome Coronavirus 2
(1 time)
Virology
(1 time)
VOC (1 time)
2021 Antiviral Effect of Budesonide against SARS-CoV-2.
47  showed no inhibition activity against TMPRSS2 at its IC50
(1 time)
Complementary Therapies
(1 time)
MD (1 time)
Mpro (1 time)
RdRp (1 time)
2022 Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2.
48  sickness coronavirus 2
(1 time)
Molecular Biology
(1 time)
--- 2020 Is BCG vaccination causally related to reduced COVID-19 mortality?
49  similarity between syndrome coronavirus 2
(1 time)
Biology
(1 time)
COVID-19 (1 time)
2021 Advances, challenges and opportunities of phylogenetic and social network analysis using COVID-19 data.
50  Since December 2019, a number of patients infected with COVID-19
(1 time)
Pediatrics
(1 time)
--- 2020 Analysis and suggestions for the preview and triage screening of children with suspected COVID-19 outside the epidemic area of Hubei Province.
51  Since December 2019, COVID-19, caused by the new coronavirus
(1 time)
Medicine
(1 time)
CNKI (1 time)
REDI (1 time)
XFF (1 time)
2020 The curative effect of Reduning injection combined with Xuanfeibaidu formula on COVID-19: A protocol for systematic review and meta-analysis.
52  Since December 2019, pneumonia caused by a novel coronavirus
(1 time)
Medicine
(1 time)
CRP (1 time)
CT (1 time)
ESR (1 time)
2021 Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study.
53  Since in late 2019, when the coronavirus 2
(1 time)
COVID-19 (1 time)
2021 Food Containing Bioactive Flavonoids and Other Phenolic or Sulfur Phytochemicals With Antiviral Effect: Can We Design a Promising Diet Against COVID-19?
54  Since the outbreak of 2019 novel coronavirus
(1 time)
Virology
(1 time)
COVID-19 (1 time)
IL (1 time)
ILD (1 time)
2020 Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China.
55  Since the outbreak of the new coronavirus in 2019
(1 time)
Cell Death
(1 time)
COVID-19 (1 time)
2020 SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?
56  single-stranded RNA virus, SARS-coronavirus 2
(1 time)
Cell Biology
(1 time)
--- 2022 Role of the Microbiome in the Pathogenesis of COVID-19.
57  site of infection with Coronavirus-2
(1 time)
Optometry
(1 time)
ACE2 (1 time)
COVID-19 (1 time)
2020 The ocular surface, coronaviruses and COVID-19.
58  Source of Cannabinoids against Coronavirus 2
(1 time)
Biology
(1 time)
ACE2 (1 time)
2022 The Role of Cannabis sativa L. as a Source of Cannabinoids against Coronavirus 2 (SARS-CoV-2): An In Silico Study to Evaluate Their Activities and ADMET Properties.
59  specific against the novel coronavirus 2019
(1 time)
Chemistry Techniques, Analytical
(1 time)
DBS (1 time)
SPR (1 time)
2021 Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.
60  spread of Coronavirus 2 infection
(1 time)
Nephrology
(1 time)
COVID-19 (1 time)
2022 COVID-19 vaccination and penile Mondor disease. There is any relationship?
61  spread of public awareness of the 2019 novel coronavirus
(1 time)
Natural Science Disciplines
(1 time)
--- 2020 The impact of social ties and SARS memory on the public awareness of 2019 novel coronavirus (SARS-CoV-2) outbreak.
62  standard for detecting the causative coronavirus 2
(1 time)
Natural Science Disciplines
(1 time)
PCR (1 time)
2022 Reliability of crowdsourced data and patient-reported outcome measures in cough-based COVID-19 screening.
63  Stay-at-home orders in response to the Coronavirus 2
(1 time)
Delivery of Health Care
(1 time)
--- 2022 Lifestyle in Obese Individuals during the COVID-19 Pandemic.
64  still challenged with COVID-19 pandemic caused by Coronavirus-2
(1 time)
Environmental Health
(1 time)
--- 2022 Efficacy of selected Nigerian tropical plants in the treatment of COVID-19: in silico and in vitro investigations.
65  Still's Disease following Coronavirus 2
(1 time)
AOSD (1 time)
2022 Adult-Onset Still's Disease following Coronavirus 2 (SARS-CoV-2) Vaccination: A Case Report.
66  strategies for coronavirus 2
(1 time)
Medicine
(1 time)
COVID-19 (1 time)
MEURI (1 time)
2020 An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine.
67  Strategies to halt 2019 novel coronavirus
(1 time)
Transplantation
(1 time)
--- 2020 Strategies to halt 2019 novel coronavirus (SARS-CoV-2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China.
68  study of 289 patients diagnosed with 2019 Novel Coronavirus
(1 time)
Cardiology
(1 time)
ACEIs (1 time)
ARBs (1 time)
COVID-19 (1 time)
2021 Renin-Angiotensin System Blocker in COVID-19. A Single Center Study.
69  Study on Knowledge, Behavior, and Attitude Toward Novel Coronavirus 2019
(1 time)
Public Health
(1 time)
--- 2020 A Study on Knowledge, Behavior, and Attitude Toward Novel Coronavirus 2019 (SARS-CoV-2) Among the Jordanian Population.
70  subsequently defined as the new coronavirus of 2019
(1 time)
Medicine
(1 time)
ICU (1 time)
2020 [Intensive care during the 2019-coronavirus epidemic].
71  such as corona virus-2
(1 time)
Pharmacology
(1 time)
EGCG (1 time)
HIV (1 time)
2021 A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV.
72  such as the coronavirus 2
(1 time)
Environmental Health
(1 time)
--- 2020 A Systems Approach to Assess Transport and Diffusion of Hazardous Airborne Particles in a Large Surgical Suite: Potential Impacts on Viral Airborne Transmission.
73  suggesting that infection with coronavirus 2
(1 time)
Medicine
(1 time)
--- 2021 Hashimoto's thyroiditis following SARS-CoV-2 infection.
74  surfaces used by health care workers and patients in coronavirus-2
(1 time)
Environmental Health
(1 time)
--- 2021 Evaluation of masks' internal and external surfaces used by health care workers and patients in coronavirus-2 (SARS-CoV-2) wards.
75  suspected for novel Coronavirus 2019
(1 time)
Radiology
(1 time)
--- 2020 Diagnostic impact of bedside chest X-ray features of 2019 novel coronavirus in the routine admission at the emergency department: case series from Lombardy region.
76  sustained by the 2019 novel coronavirus
(1 time)
Chemistry, Clinical
(1 time)
FDP (1 time)
FIB (1 time)
PT-act (1 time)
2020 Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
77  swab for 2019-novel coronavirus
(1 time)
General Surgery
(1 time)
--- 2020 Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes.
78  symptomatic real-time reverse transcriptase- polymerase chain reaction-confirmed coronavirus 2
(1 time)
Communicable Diseases
(1 time)
--- 2022 Gamma variant vertically transmitted from a mild symptomatic pregnant woman associated with fatal neonatal COVID.
79  syndrome caused by the Coronavirus-2 virus
(1 time)
GI (1 time)
2022 Optimal COVID-19 epidemic strategy with vaccination control and infection prevention measures in Thailand.
80  syndrome causing coronavirus type-2
(1 time)
COVID-19 (1 time)
RBD (1 time)
2022 Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design.
81  syndrome coronavirus 2 novel coronavirus
(1 time)
COVID-19 (1 time)
DL (1 time)
Mpro (1 time)
2022 Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations.
82  syndrome coronavirus 2(refs.1,2)
(1 time)
Science
(1 time)
--- 2022 Coronaviruses exploit a host cysteine-aspartic protease for replication.
83  syndrome coronavirus 2-associated
(1 time)
COVID-19 (1 time)
SNP (1 time)
2021 Associations between Allelic Variants of the Human IgH 3' Regulatory Region 1 and the Immune Response to BNT162b2 mRNA Vaccine.
84  Syndrome Coronavirus Disease 2019
(1 time)
Public Health
(1 time)
LTCFs (1 time)
2021 The Main Issues and Challenges Older Adults Face in the SARS-CoV-2 Pandemic: A Scoping Review of Literature.
85  syndrome coronavirus virus respiratory type 2
(1 time)
Pharmacology
(1 time)
BBB (1 time)
COVID-19 (1 time)
2022 Citicoline and COVID-19: vis-a-vis conjectured.
86  syndrome coronavirus-2 pandemic
(1 time)
AKI (1 time)
ARDS (1 time)
HFNC (1 time)
2022 Comparing India's Second COVID Wave with the First Wave-A Single-Center Experience.
87  syndrome following coronavirus 2 infection
(1 time)
Neurology
(1 time)
COVID-19 (1 time)
MRI (1 time)
PT (1 time)
2022 Shoulder palsy following SARS-CoV-2 infection: two cases of typical Parsonage-Turner syndrome.
88  syndrome has been classified as a corona virus 2
(1 time)
Environmental Health
(1 time)
COVID-19 (1 time)
PHEIC (1 time)
2021 Environmental and health impacts of spraying COVID-19 disinfectants with associated challenges.
89  syndrome involving corona virus-2
(1 time)
Chemical Phenomena
(1 time)
--- 2022 Assessing the Vulnerability of Cancer Patients for COVID-19.
90  syndrome type 2-causing coronavirus
(1 time)
Biomedical Research
(1 time)
--- 2022 Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies.
91  syndrome, associated with coronavirus 2
(1 time)
Clinical Trials as Topic
(1 time)
COVID-19 (1 time)
2021 Doxycycline in the Coronavirus Disease 2019 Therapy.
92  syndrome-related coronavirus-2, the viral pathogen causing COVID-19 disease
(1 time)
COVID-19 (1 time)
SIR (1 time)
2020 Creating and applying SIR modified compartmental model for calculation of COVID-19 lockdown efficiency.